Introducing the world’s first AI-powered clinical tool designed specifically to help patients safely reduce or stop medications that may be harmful or no longer necessary.
Built in-house by our teams of clinicians and AI engineers, this groundbreaking clinical decision support tool helps patients check if their medication can be reduced or stopped. A report is then produced for the user to then pass on to their physician, which provides an evidence-based protocol to help the provider access the benefits of deprescribing and also the method to use. Taken altogether, the NowPatient AI Deprescribing Advisor supports better outcomes, fewer side effects, and smarter prescribing.
Deprescribing just went digital, and it’s a game changer.
You can learn more about the AI Deprescribing Advisor today!
About NowPatient's Editorial Process
- Written by clinical authors
- Reviewed every 2 years
- Conflicts of interest declared
NowPatient's medical content is selected by a panel of practising clinicians (pharmacists, doctors and allied healthcare professionals) and researched by an in-house team of writers who all hold scientific or clinical backgrounds. Sponsorship and conflicts of interest are openly declared.
Every article is peer-reviewed by a clinician for clinical accuracy, evidence base and accessibility, including consideration of the particular characteristics set out in the UK Equality Act 2010. Only then is it released for publication against fixed placement guidelines.
All content is cycle reviewed (typically every two years) and updated sooner if evidence, guidelines or a complaint require it. Changes follow a formal change control procedure and are reflected in the "last updated" date on each article. NowPatient is governed by MiHealth; UK pharmacy services are provided by MiHealth Pharmacy (GPhC 1036487).































